Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Payables (2019 - 2025)

Outset Medical (OM) has disclosed Payables for 7 consecutive years, with $554000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Payables fell 85.66% to $554000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $554000.0, a 85.66% decrease, with the full-year FY2025 number at $554000.0, down 85.66% from a year prior.
  • Payables was $554000.0 for Q4 2025 at Outset Medical, down from $1.7 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $6.8 million in Q1 2024 to a low of $554000.0 in Q4 2025.
  • A 5-year average of $3.1 million and a median of $2.5 million in 2021 define the central range for Payables.
  • Peak YoY movement for Payables: soared 866.33% in 2023, then plummeted 85.66% in 2025.
  • Outset Medical's Payables stood at $1.8 million in 2021, then crashed by 65.8% to $603000.0 in 2022, then skyrocketed by 866.33% to $5.8 million in 2023, then crashed by 33.72% to $3.9 million in 2024, then tumbled by 85.66% to $554000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Payables are $554000.0 (Q4 2025), $1.7 million (Q3 2025), and $1.4 million (Q2 2025).